Leading Pharmaceutical and Biopharmaceutical Company | Pfizer

 

News

Important Update on EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors

Extended Expiration Dates for Select Lots of EpiPen® 0.3 mg Auto-Injectors and Its Authorized Generic

View the update
Our Science

Phenotypic Drug Discovery Makes a Comeback

Phenotypic approaches may also help discover new biological processes and targets.

Read More
Your Health

Addressing the Unique Health Needs of African Americans

The African American Health Engagement Study examines the health attitudes and behaviors of African Americans.

Read The Study Findings
Your Health

Is Sitting Behind Your Desk Bad for Your Health?

If you sit for long periods of time each day working on a computer, you may be at risk for developing physical strain and overuse injuries.

Learn More

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Advanced Search
Our Science

How to Deal Dangerous Proteins a Knockout Blow

Getting rid of a problematic protein, however, isn’t easy. Since DNA and RNA contain the code for creating individual proteins, scientists long focused on these two nucleic acids as the key to purging proteins.

Learn More
Your Health

5 Facts About Real-World Data

Real-World Data (RWD) can help us further understand the effectiveness, safety and costs associated with a treatment option, potentially offering complementary insights to clinical trial findings.

See The 5 Facts Of RWD
Latest news
Pfizer Receives Breakthrough Therapy Designation...

Pfizer Inc. (NYSE:PFE) today announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with alopecia areata, a chronic...

Read more